Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 141.30 4.40
Tata Mot 428.65 4.24
Bhel 181.05 3.10
Tata Stl 418.80 1.22
Ntpc Ltd 123.05 0.37
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Abbott India Limited
Abbott India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500488NSE:ABBOTINDIABloomberg:BOOT@INReuters:ABOT.BO
Market Lot: 1Face Value: 10ISIN Demat: INE358A01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
04-JUN-13 Abbott India announced that the board of directors has decided to defer the proposal received by the company for the sale and transfer of other appropriate restructuring of, the proprietary pharmaceuticals division. 21-FEB-13 Abbott India, the company working to advance health care for people announced fall of 34.95% in its net profit to Rs 497.7 million for the quarter ended Dec. 31, 2012 as compared to Rs 368.8 million in the same ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
'Buy' Abbott India; target price Rs 1,488: Firstcall Research  -IRIS 26-Aug-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2013(12)31-Dec-2012(12)31-Dec-2011 (12)
Net sales 17527.4016130.9014455.70
Other Income388.30223.10193.30
Total Income17915.7016354.0014649.00
Cost of goods sold15851.1014508.9013016.30
OPBDIT2064.601845.101632.70
PAT1600.601447.001203.90
Gross Block---
Equity capital212.50212.50212.50
EPS (Rs.)--56.66
DPS (Rs.)---
BV (Rs.)---
P/E range (x)--20.79 - 29.70
Debt / Equity (x)---
Operating margin (% of OI)11.511.311.1
Net margin (% of OI) 8.9 8.8 8.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
3 - 4, Corporate Park
Sion Trombay Road
Mumbai
Maharashtra-400 071
PHONE
(022) 6797 8888
FAX
(022) 6797 8727
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer